Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands.

The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the cannabis sector.

Organigram reports that it cultivates and internally extracts THCV at its state-of-the-art Moncton facility, establishing itself as the sole licensed Canadian producer to undertake this process.

Reshaping Cannabis Experiences Through Strategic Investments

Megan McCrae, senior VP of marketing and communications at Organigram, emphasized the company's commitment to exceeding consumer expectations and reshaping the cannabis experience …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.